PERSPECTIVES

We have a responsibility to build upon the incredible progress that has been made in understanding the biology of disease and to develop life-changing medicines that allow for sustainable, equitable access. We’ve seen success in other industry’s market-based, disruptive solutions - now is the time for healthcare.

Bio

Alexis Borisy is a leading biotechnology entrepreneur and investor with more than 25 years of experience, including founding, being the CEO, and/or Chairman of 9 NASDAQ listed companies. He co-founded and served as either the CEO or Chairman of Blueprint Medicines, Foundation Medicine, Relay Therapeutics, Tango Therapeutics, Celsius Therapeutics, and CombinatoRx. He’s also a founding investor for Editas Medicine, Magenta Therapeutics, Revolution Medicines and Thrive Earlier Detection. Alexis is the Chairman of the Board of Trustees of the Boston Museum of Science, and is past Chairman of the National Venture Capital Association. He holds a master’s degree in chemistry and chemical biology from Harvard University and a B.S. in chemistry from the University of Chicago.

View All